Back to Search
DANICE BLAISE, MD,MBA
MD,MBA
General Practice Physician
NPI: 1255829966IndividualAccepts Medicare
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
ACN1418(FL)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
25173(NH)
Physician Assistant
Physician Assistant
Code: 363A00000X
2019045102(MO)CV2000213(IN)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryGENERAL PRACTICE
Education
OTHER
Class of 2017
Research & Publications (20)
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.
PMID 19584825·Bone Marrow Transplant·2010
8-other
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation.
PMID 19584826·Bone Marrow Transplant·2010
4-observational
Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin.
PMID 19228940·Blood·2009
8-other
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison.
PMID 18580956·Leukemia·2009
4-observational
Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission.
PMID 19597030·J Clin Oncol·2009
8-other
Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL.
PMID 19197723·Leuk Lymphoma·2009
5-case
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
PMID 18390969·J Clin Oncol·2008
4-observational
High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
PMID 18287132·Haematologica·2008
4-observational
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
PMID 18469352·Haematologica·2008
8-other
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
PMID 18606981·J Clin Oncol·2008
4-observational
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
PMID 18838474·Haematologica·2008
8-other
Rituximab as salvage therapy for refractory chronic GVHD.
PMID 18278073·Bone Marrow Transplant·2008
8-other
Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor.
PMID 18282280·Crit Care·2008
3-trial
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma.
PMID 18297115·Bone Marrow Transplant·2008
8-other
Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.
PMID 18631344·Br J Haematol·2008
8-other
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
PMID 18346838·Exp Hematol·2008
4-observational
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.
PMID 18679370·Bone Marrow Transplant·2008
4-observational
Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma.
PMID 18650177·Clin Lymphoma Myeloma·2008
8-other
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
PMID 18506024·J Clin Oncol·2008
8-other
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.
PMID 18398414·Nat Clin Pract Oncol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 684 STATE ROAD 60 W
LAKE WALES, FL 33853 - Phone
- (863) 949-4868
Quick Facts
- NPI
- 1255829966
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile